IL4 and myeloid sarcoma: However, because this glycolipid stimulates NKT cells and induces the production of both interleukin (IL)-4 and interferon (IFN)-γ, a search for glycolipids that selectively induce IL-4 production was initiated to treat Th1 cytokine–dependent autoimmune diseases such as MS.